Arrhythmogenic Right Ventricular Dysplasia Cardiomyopathy

Arrhythmogenic Right Ventricular Dysplasia/ Cardiomyopathy Aiteriogenesis Arteriosclerosis Arylhydrocarbon Receptor L-Ascorbic Acid ASF Family of Transporters Asn-linked Glycosylation ASON... [Pg.1487]

APD, action potential duration ARVD/C, arrhythmogenic right ventricular dysplasia/cardiomyopathy CM, cardiomyocyte CPVT, catecholaminergic polymorphic ventricular tachycardia DAD, delayed after depolarizations DCM, dilated cardiomyopathy EAD, early after depolarization HCM, hypertrophic cardiomyopathy 1 rectifier potassium current 1, sodium current MEA, multielectrode array TNNT2, troponin T type 2. [Pg.352]

Calkins, H., Arrhythmogenic right-ventricular dysplasia/cardiomyopathy. Curr Opin Cardiol, 2006. 21(1) p. 55-63. [Pg.536]

Corrado, D., Basso, C., Thiene, G., McKenna, W. J., Davies, M. J., Fontaliran, F., Nava, A., Silvestri, F., Blomstrom-Lundqvist, C., Wlodarska, E. K., Fontaine, G., and Camerini, F. (1997). Spectrum of Clinicopathologic Manifestations of Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia a Multicenter Study. J Am Coll Cardiol 30(6) 1512-20. [Pg.309]

Corrado, D., Thiene, G. (2006). Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Clinical Impact of Molecular Genetic Studies. Circulation 113(13) 1634-7. [Pg.309]

Coirado, D., et al, Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathy/ dysplasia. Circulation, 2003. 108(25) p. 3084-91. [Pg.536]

Big Chemical Encyclopedia